ChemPartner PharmaTech Co.,Ltd. (SHE:300149)

ChemPartner PharmaTech Revenue

ChemPartner PharmaTech had revenue of 384.83M CNY in the quarter ending September 30, 2026, with 35.96% growth. This brings the company's total for the last twelve months to 1.27B, up 18.40% year-over-year. In the year 2025, ChemPartner PharmaTech had annual revenue of 1.13B with 16.96% growth. That makes ChemPartner PharmaTech the 17,855th largest company in the world by revenue and 3,260th in China.

• Revenue (ttm): 1.27B
• Revenue Growth: +18.40%
• P/S Ratio: 3.51
• Revenue / Employee: 714.38K
• Employees: 1,771
• Market Cap: 4.44B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical R & D Services and Production Outsourcing 1.14B 98.8%
• Big Health and Medical Business 8.98M 0.8%
• Headquarters and Funds 5.39M 0.5%

By Geography

Chart

• Overseas 869.74M 76.6%
• China 264.98M 23.4%

Fiscal year ended Dec 31, 2025 See the full ChemPartner PharmaTech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.13B	164.51M	16.96%
Dec 31, 2024	970.20M	-168.16M	-14.77%
Dec 31, 2023	1.14B	-188.22M	-14.19%
Jan 1, 2023	1.33B	-364.09M	-21.54%
Jan 1, 2022	1.69B	209.09M	14.11%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error